Minerva Neurosciences Inc NERV:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 1:03 PM EDT
2.56quote price arrow up+0.09 (+3.64%)
Volume
8,332
52 week range
2.26 - 13.49
Loading...
  • Open2.49
  • Day High2.52
  • Day Low2.39
  • Prev Close2.47
  • 52 Week High13.49
  • 52 Week High Date02/07/24
  • 52 Week Low2.26
  • 52 Week Low Date04/25/23

Key Stats

  • Market Cap17.903M
  • Shares Out6.99M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change-59.11

KEY STATS

  • Open2.49
  • Day High2.52
  • Day Low2.39
  • Prev Close2.47
  • 52 Week High13.49
  • 52 Week High Date02/07/24
  • 52 Week Low2.26
  • 52 Week Low Date04/25/23
  • Market Cap17.903M
  • Shares Out6.99M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change-59.11

RATIOS/PROFITABILITY

  • EPS (TTM)-4.65
  • P/E (TTM)-0.55
  • Fwd P/E (NTM)-0.70
  • EBITDA (TTM)-23.089M
  • ROE (TTM)-675.09%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)12.84%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Minerva Neurosciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focused on the development and commercialization of product candidates to treat patients suffering from central nervous system (CNS) diseases. It is engaged in developing roluperidone for the treatment of negative symptoms in patients with schizophrenia and have exclusive rights to develop and commercialize MIN-301 for the treatment of Parkinson's disease. It has also co-developed seltorexant for...
Remy Luthringer Ph.D.
Executive Chairman of the Board of Directors, Chief Executive Officer
Geoffrey Race
President
Joseph Reilly
Chief Operating Officer, Senior Vice President
Frederick Ahlholm CPA
Chief Financial Officer, Senior Vice President, Secretary
Address
1601 TRAPELO ROAD, SUITE 284
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ALZN
Alzamend Neuro Inc
0.7047-0.0194-2.6792%
GLTO
Galecto Inc
0.7141+0.0397+5.8867%
EVAX
Evaxion Biotech A/S
4.20+0.09+2.21%
OTLC
Oncotelic Therapeutics Inc
0.04-0.0009-2.2005%
TRAW
Traws Pharma Inc
0.6853+0.0026+0.3808%